stockrowACADIA Pharmaceuticals Inc.
ACAD Healthcare Biotechnology
ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024.
- Revenue
- +22.9%
- EPS
- −27.9%
- Free cash flow
- +141.2%
Quarter to September 2026, against a year earlier
Follow ACAD
Alert me
ACADIA Pharmaceuticals Inc. (ACAD) Operating margin
ACADIA Pharmaceuticals Inc.'s operating margin over the twelve months to 30 September 2026 was 10.2%, up 0.4 percentage points from fiscal 2025 (9.78%). Over the past ten years it has ranged from −269,855.7% (fiscal 2015) to 24.1% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 9.78% | (14.32) |
| FY2024 | 24.1% | 34.20 |
| FY2023 | −10.1% | 33.13 |
| FY2022 | −43.2% | (8.03) |
| FY2021 | −35.2% | 29.67 |
| FY2020 | −64.9% | 7.84 |
| FY2019 | −72.7% | 37.85 |
| FY2018 | −110.6% | 123.55 |
| FY2017 | −234.1% | 1,340.03 |
| FY2016 | −1,574.1% | 268,281.60 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 21.0% | 8.66 |
| Jun 2026 | 12.3% | 14.01 |
| Mar 2026 | −1.72% | (7.84) |
| Dec 2025 | 6.12% | (6.71) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ACAD ACADIA Pharmaceuticals Inc. | 10.2% |
| XENE Xenon Pharmaceuticals Inc. compare | 0.00% |
| DYN Dyne Therapeutics, Inc. compare | 0.00% |
| IRON Disc Medicine, Inc. compare | 0.00% |
| PBLS Parabilis Medicines, Inc. compare | 0.00% |
| TNGX Tango Therapeutics, Inc. compare | 0.00% |
| VKTX Viking Therapeutics, Inc. compare | 0.00% |
| IOVA Iovance Biotherapeutics, Inc. compare | −60.8% |
| RLAY Relay Therapeutics, Inc. compare | −2,815.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ACAD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement